Takeda

Takeda’s U.S. operations are centered in Cambridge, where the Japanese biopharmaceutical company runs its global hub and research center in Kendall Square. Takeda describes itself as the largest life sciences employer in Massachusetts, and its work spans treatments for rare diseases, blood disorders, cancers and other serious conditions. Recent U.S. approvals include ORZEYFUL for narcolepsy type 1 and MIMRYLO for polycythemia vera, both first-in-class medicines that mark new options for patients with those conditions.

Beyond its labs, the company invests in local partnerships, including a collaboration with The Greater Boston Food Bank to advance community health. It also partners to support progress for people with rare diseases and explores ways for patients to receive care closer to home. Takeda has deep roots in Japan, where it was founded in 1781, and it became a major Massachusetts employer after acquiring Cambridge-based Millennium Pharmaceuticals in 2008 and later Shire.

What to Know

• Takeda has U.S. sites in 39 states.
• It offers GAMMAGARD LIQUID ERC, a ready-to-use immunoglobulin therapy with low IgA content.
• Takeda presents hematology and oncology research at major medical meetings such as the American Society of Hematology annual meeting.
• The company is listed with the East Cambridge Business Association.